Nestlé brand launches infant gut health guide to close parents’ information gap
SMA Nutrition has launched The Infant Gut Health Journey, which addresses parents’ needs after finding that 82% of…
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
First gene replacement therapy in the EU for broad population with SMA, including children two years and older,…
KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)
This is a letter to Roche requesting a voluntary license to the patents on risdiplam, a treatment for…